Why Scott Rocklage Believes that Prioritization and Time Management are the Determinants of Productivity

Scott Rocklage is an entrepreneur who believes that business goals are only achievable in an enterprise if the right people are hired. He draws most of his inspiration to become a better entrepreneur from a book called “Good to Great.” This book outlines the basic rules of understanding business and performance.

As he was venturing into entrepreneurship, Rocklage learned that business management is all about flexibility. An entrepreneur should adopt strategies that match the financial times.

He also learned that risk-taking is effective when a business venture is at its beginning stages. Rocklage manages to be productive in his activities through planning. In this context, planning entails prioritization, calendaring, and time management. Read more: Scott Racklage | Bloomberg

According to Scott Rocklage, trends in the market make the business sector interesting. He is impressed by how specific genotypes or mutations are used in modern medical activities to remedy cancer. He believes that these treatments are saving and extending people’s lives.

Academic and work background

Scott Rocklage earned his B.S in chemistry degree after attending the famed University of California, Berkeley. He pursued a doctorate course in chemistry at MIT. Rocklage was fortunate enough to do his postgraduate research at MIT’s Richard Schrock chemistry lab.

With over 30 years of experience on strategic leadership matters in the healthcare industry, Scott Rocklage has been involved with several companies. In 2003, he accepted a venture partner job offer at 5 AM Venture. He was also promoted to managing partner a year later.

Rocklage also held the positions of CEO and board chair at Cubist Pharmaceuticals, R&D at Salutar and Catalytica and president and CEO at Nycomed Salutar. He serves in the capacity of board chairperson at Cidara Rennovia and Kinestral and board member at Pulmatrix and Epirus.

Career achievements

Throughout his three decades career, Rocklage’s strategic leadership efforts were instrumental in the approval of three drugs. The FDA approved drugs include Cubicin, Teslascan, and Omniscan.

Rocklage patented over 20 technologies and products that are currently being used in the healthcare industry. He is also credited with writing over 100 articles that are available on online peer-reviewed journals.